Back to the main directory
Company Analysis / Equity
- Aveo’s Reputation King Hit on All Four Corners; FVE Cut to AUD 3.10 by Morningstar
- NTT’s 2Q On Track With Another Large Buyback Announced to Support the Stock Price by Morningstar
- Japan Exchanges Visit: Liberalization of Energy Markets an Opportunity for Derivatives Market by Morningstar
- Valero Energy Partners is an MLP operating logistics assets supporting its refining sponsor. by Morningstar
- Alliance's growth has been impressive, but we worry about approaching headwinds. by Morningstar
- Amazon Top-Line Trends Signal Prime Member/Third-Party Seller Engagement, Category Expansion Options by Morningstar
- Maintaining Our BioMarin FVE Following In-Line R&D Day and 3Q Performance by Morningstar
- Anthem Transitions its PBM Contract to CVS, Express Remains in a Favorable Long-Term Position by Morningstar
- KPN's consumer business continues to grow while the business segment struggles. by Morningstar
- Vertex's cystic fibrosis portfolio creates a narrow moat in this lucrative rare disease. by Morningstar
- Allergan Loses Restasis Patent Battle, but Long-Term Outlook Remains Intact; Shares Undervalued by Morningstar
- Chipotle Establishes 2018 as a Transition Year, Building a Foundation for More Stable Growth by Morningstar
- Hanesbrands Poised to Return to Organic Growth And Makes Acquisition; Shares Undervalued by Morningstar
- Cimic In Line With Expectations at the 2017 3Q Mark; No Change in View by Morningstar
- LSE Posts Strong 2Q Earnings on the Heels of Incoming MiFID II Implementation by Morningstar
- China Shenhua's integrated business model shows resilience in challenging environments. by Morningstar
- Volume Growth Evaporates in 3Q for Unilever, but Operating Changes Should Help by Morningstar
- Several Undervalued Banks Stand to Benefit from 2017 CCAR Results and Capital Return Plans by Morningstar
- Maintaining Tenaris FVE Despite Positive 3Q Results; Shares Look Slightly Overvalued by Morningstar
- Lear Reports Record 2Q Results; Maintaining $103 FVE by Morningstar
- Infratil is a play on renewable energy and retirement-care services, which are in strong demand. by Morningstar
- Catastrophes Take Toll in Chubb's 3Q, but Underlying Results Strong by Morningstar
- More Asset Managers Providing Monthly AUM is a Good Thing; BlackRock and T. Rowe Price Our Top Picks by Morningstar
- Despite an improving drug pipeline, Astra still faces headwinds with its massive patent losses. by Morningstar
- Boeing's backlog of over 5,700 commercial aircraft provides future growth visibility. by Morningstar